Reducing the cost of headache medication. Curr Pain Headache Rep 2009 Jun;13(3):227-30
Date
05/22/2009Pubmed ID
19457284DOI
10.1007/s11916-009-0038-5Scopus ID
2-s2.0-65649154518 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
Although medication costs make up one of the smallest portions of the overall expense of headache care, it is the segment of expense that often impacts the patient most directly. The advent of triptans marked a major advance in migraine therapy, but their high cost has limited their widespread use. Four options can be considered as potential means to reduce the cost of triptans. These include compulsory licensing, exclusive contracting, over-the-counter -availability, and the introduction of generic triptans. Each method impacts the consumer, third-party payer, or pharmaceutical company in a different manner.
Author List
Solomon GDAuthor
Glen D. Solomon MD Professor in the Neurology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsCost Savings
Drugs, Generic
Headache
Humans
Migraine Disorders
Nonprescription Drugs
Tryptamines
